A detailed history of Sws Partners transactions in Abbott Laboratories stock. As of the latest transaction made, Sws Partners holds 20,938 shares of ABT stock, worth $2.4 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
20,938
Previous 25,081 16.52%
Holding current value
$2.4 Million
Previous $2.61 Million 8.4%
% of portfolio
0.77%
Previous 0.79%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$100.07 - $118.13 $414,590 - $489,412
-4,143 Reduced 16.52%
20,938 $2.39 Million
Q2 2024

Jul 17, 2024

SELL
$100.73 - $112.44 $17,929 - $20,014
-178 Reduced 0.7%
25,081 $2.61 Million
Q1 2024

Apr 30, 2024

BUY
$109.52 - $120.96 $186,841 - $206,357
1,706 Added 7.24%
25,259 $2.87 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $227,729 - $278,760
-2,525 Reduced 9.68%
23,553 $2.59 Million
Q3 2023

Nov 09, 2023

BUY
$95.53 - $114.62 $304,836 - $365,752
3,191 Added 13.94%
26,078 $2.53 Million
Q2 2023

Aug 17, 2023

SELL
$100.78 - $112.29 $1.64 Million - $1.83 Million
-16,257 Reduced 41.53%
22,887 $2.5 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $1.64 Million - $1.83 Million
16,257 Added 71.03%
39,144 $4.27 Million
Q2 2023

Jul 26, 2023

SELL
$100.78 - $112.29 $102,694 - $114,423
-1,019 Reduced 4.26%
22,887 $2.5 Million
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $86,205 - $101,468
890 Added 3.87%
23,906 $2.42 Million
Q4 2022

Jan 30, 2023

BUY
$95.06 - $111.52 $238,885 - $280,249
2,513 Added 12.26%
23,016 $2.53 Million
Q3 2022

Nov 09, 2022

BUY
$96.76 - $112.03 $45,767 - $52,990
473 Added 2.36%
20,503 $1.98 Million
Q2 2022

Jul 28, 2022

SELL
$102.07 - $123.37 $1,735 - $2,097
-17 Reduced 0.08%
20,030 $2.18 Million
Q1 2022

May 05, 2022

BUY
$114.02 - $139.04 $114,476 - $139,596
1,004 Added 5.27%
20,047 $2.38 Million
Q4 2021

Jan 25, 2022

SELL
$115.53 - $141.46 $1.42 Million - $1.74 Million
-12,322 Reduced 39.29%
19,043 $2.68 Million
Q3 2019

Nov 15, 2019

BUY
$81.84 - $88.74 $2.57 Million - $2.78 Million
31,365 New
31,365 $2.72 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $97,926 - $108,081
-1,701 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $6,752 - $7,634
-120 Reduced 6.59%
1,701 $99,000
Q4 2017

Feb 15, 2018

BUY
$53.68 - $57.47 $97,751 - $104,652
1,821
1,821 $104,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sws Partners Portfolio

Follow Sws Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sws Partners, based on Form 13F filings with the SEC.

News

Stay updated on Sws Partners with notifications on news.